Correction: MAIA Biotechnology Announces $695,000 Private Placement This is a correction of the announcement. The number of shares and expected proceeds from the private placement have been corrected to 463,332…
Puma Biotechnology Showcases Promising Neratinib Combination Data at AACR Annual Meeting 2025 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company specializing in the development of innovative cancer treatments, has presented…
Vir Biotechnology Reports Positive Data in Ongoing Trials for VIR-5818 and VIR-5500 Vir Biotechnology, Inc. (Nasdaq: VIR) has presented encouraging preliminary Phase 1 data from two of its dual-masked T-cell…
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, has announced the launch of its ALISCA™-Breast1 Phase II trial (PUMA-ALI-1201; NCT06369285). The study will evaluate alisertib, in combination with endocrine therapy,…
Vir Biotechnology, Inc. (NASDAQ:VIR) today revealed positive results from the SOLSTICE Phase 2 clinical trial evaluating its investigational combination of tobevibart and elebsiran for the treatment of chronic hepatitis delta…
Cyrus Biotechnology, Inc., a Seattle-based biotech company leveraging a novel hybrid AI/screening platform for biologics discovery, will showcase its expertise in protein engineering and risk mitigation for therapeutics at the…
Eradivir to Showcase Novel Antiviral Approaches at ESCMID Global and ICAR 2026 Eradivir a clinical-stage biotechnology company focused on developing innovative therapies for infectious diseases, has announced its participation in…
CareDx to Divest Lab Products Business for $170 Million, Reports Strong Q1 2026 Growth CareDx, Inc. has announced a definitive agreement to sell its Lab Products business to Eurobio Scientific…
AACR 2026: STC-1010 Shows Safety & Early Immune Activity in MSS CRC Brenus Pharma, a clinical-stage biotechnology company based in Lyon, France, has announced the presentation of new first-in-human data…
Cryo-Cell International, Inc. Reports Fiscal First Quarter 2026 Financial Results Cryo-Cell International a pioneer in the cord blood banking industry, has announced its financial results for the first quarter of…
Prothena strengthens executive leadership with key appointments and strategic role transitions to support future growth Prothena Corporation plc, a late-stage clinical biotechnology company focused on addressing diseases driven by protein…
Charles River and American Heart Association Join Forces to Advance Cardiovascular Health Cardiovascular disease (CVD) continues to pose one of the most significant public health challenges globally, affecting millions of…